Protective effect of emodin against airway inflammation in the ovalbumin-induced mouse model

Chinese Journal of Integrative Medicine

Volumn 21, Issue 6, 2015, Pages 431-437

  Wang, Tan ^a   Zhong, Xiang gen ^a   Li, Yu hang ^a   Jia, Xu ^a   Zhang, Shu jing ^a   Gao, Yu shan ^a   Liu, Miao ^a   Wu, Ruo han ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

airway inflammation; asthma; Chinese medicine; emodin

Indexed keywords

EMODIN; EOTAXIN; GELATINASE B; HEME OXYGENASE 1; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; OVALBUMIN; CHEMOKINE; INTERLEUKIN DERIVATIVE; PROTECTIVE AGENT;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL COUNT; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HISTOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATORY CELL; LUNG LAVAGE; LUNG PARENCHYMA; MOUSE; NONHUMAN; OVALBUMIN-INDUCED AIRWAY INFLAMMATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SENSITIZATION; ANIMAL; BLOOD; BRONCHOALVEOLAR LAVAGE FLUID; C57BL MOUSE; CHEMISTRY; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LEUKOCYTE; LUNG; METABOLISM; PATHOLOGY; PNEUMONIA;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES; DISEASE MODELS, ANIMAL; EMODIN; FEMALE; GENE EXPRESSION REGULATION; HEME OXYGENASE-1; IMMUNOGLOBULIN E; INTERLEUKINS; LEUKOCYTES; LUNG; MATRIX METALLOPROTEINASE 9; MICE, INBRED C57BL; OVALBUMIN; PNEUMONIA; PROTECTIVE AGENTS; RNA, MESSENGER;

EID: 84930864079     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-014-1898-z     Document Type: Article

References (34)

1. Lee YS, Han OK, Park CW, Yang CH, Jeon TW, Yoo WK, et al. Pro-inflammatory cytokine gene expression and nitric oxide regulation of aqueous extracted Astragali radix in RAW 264.7 macrophage cells. J Ethnopharmacol 2005;100:289–294.
2. Elias JA, Lee CG, Zheng T, Ma B, Homer RJ, Zhu Z. New insights into the pathogenesis of asthma. J Clin Invest 2003;111:291–297.
3. Kay AB. Allergy and allergic diseases. First of two parts. N Engl J Med 2001;344:30–37.
4. Lu Y, Yang JH, Li X, Hwangbo K, Hwang K, Taketomi Y, et al. Emodin, a naturally occurring anthraquinone derivative, suppresses IgE-mediated anaphylactic reaction and mast cell activation. Biochem Pharmacol 2011;82:1700–1708.
5. Song ZC, Wang ZS, Bai JH, Li Z, Hu J. Emodin, a naturally occurring anthraquinone, ameliorates experimental autoimmune myocarditis in rats. Tohoku J Exp Med 2012;227:225–230.
6. Chen ZF, Zhang L, Yi JY, Yang ZB, Zhang ZJ, Li Z. Promotion of adiponectin multimerization by emodin: a novel AMPK activator with PPARβ-agonist activity. J Cell Biochem 2012;11:3547–3558.
7. Marino R, Theraisingam T, Camateros P, Kanagaratham C, Xu YZ, Henri J, et al. Secretory leukocyte protease inhibitor plays an important role in the regulation of allergic asthma in mice. J Immunol 2011;7:4433–4442.
8. Papi A, Caramori G, Adcock IM, Barnes PJ. Rescue treatment in asthma. More than as-needed bronchodilation. Chest 2009;135:1628–1633.
9. Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet 2009;373:1905–1917.
10. Ohkawara Y, Lei XF, Stämpfli MR, Marshall JS, Xing Z, Jordana M. Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation. Am J Respir Cell Mol Biol 1997;16:510–520.
11. Wegmann M, Fehrenbach H, Fehrenbach A, Held T, Schramm H, Garn H, et al. Involvement of distal airways in a chronic model of experimental asthma. Clin Exp Allergy 2005;35:1263–1271.
12. Yamaoka KA, Dugas B, Paul-Eugene N, Mencia-Huerta JM, Braquet P, Kolb JP. Leukotriene B4 enhances IL-4-induced IgE production from normal human lymphocytes. Cell Immunol 1994;156:124–134.
13. Robinson D, Hamid Q, Bentley A, Ying S, Kay AB, Durham SR. Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993;92:313–324.
14. Palframan RT, Collins PD, Williams TJ, Rankin SM. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood 1998;91:2240–2248.
15. Choi AM, Alam J. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidantinduced lung injury. Am J Respir Cell Mol Biol 1996;15:9–19.
16. Barnes PJ. Reactive oxygen species and airway inflammation. Free Radic Biol Med 1990;9:235–243.
17. Kharitonov SA, Chung KF, Evans D, O’Connor BJ, Barnes PJ. Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract. Am J Respir Crit Care Med 1996;153:1773–1780.
18. Carter EP, Garat C, Imamura M. Continual emerging roles of HO-1: protection against airway inflammation. Am J Physiol Lung Cell Mol Physiol 2004;287:L24–L25.
19. Ryter SW, Alam J, Choi MK. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 2006;86:583–650.
20. Fredenburgh LE, Perrella MA, Mitsialis SA. The role of heme oxygenase-1 in pulmonary disease. Am J Respir Cell Mol Biol 2007;36:158–165.
21. Vogt BA, Alam J, Croatt AJ, Vercelloth GM, Nath KA. Acquired resistance to acute oxidative stress. Possible role of heme oxygenase and ferritin. Laborat Invest 1995;72:474–483.
22. Almolki A, Taille C, Martin GF, Jose PJ, Zedda C, Conti M, et al. Heme oxygenase attenuates allergen-induced airway inflammation and hyperreactivity in guinea pigs. Am J Physiol Lung Cell Mol Physiol 2004;287:L26–L34.
23. Keshavan P, Deem TL, Schwemberger SJ, Babcock GF, Cook-Mills JM, Zucker SD. Unconjugated bilirubin inhibits VCAM-1-mediated transendothelial leukocyte migration. J Immunol 2005;174:3709–3718.
24. Kelly EA, Busse WW, Jaejour NN. Increased matrix metalloproteinase-9 in the airway after allergen challenge. Am J Respir Crit Care Med 2000;162:1157–1161.
25. Mautino G, Oliver N, Chanez P, Bousquet J, Capony M. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatic. Am J Respir Cell Mol Biol 1997;17:583–591.
26. Pérez-Ramos J, de Lourdes Segura-Valdez M, Vanda B, Selman M, Pardo A. Matrix metalloproteinases 2, 9, and 13, and tissue inhibitors of metalloproteinases 1 and 2 in experimental lung silicosis. Am J Respir Crit Care Med 1999;160:1274–1282.
27. Tan RJ, Fattma CL, Niehouse LM, Tobolewski JM, Hanford LE, Li Q. Matrix metalloproteinases promoted inflammation and fibrosis in asbestosis-induced lung injury in mice. Am J Respir Cell Mol Biol 2006;35:289–297.
28. Okada S, Kita H, George TJ, Gleich GJ, Leiferman KM. Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol 1997;17:519–528.
29. Delclaux C, Delacourt C, D’Ortho MP, Boyer V, Lafuma C, Harf A. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol 1996;14:288–295.
30. Cataldo D, Munaut C, Noël A, Frankenne F, Bartsch P, Foidart JM, et al. MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Intern Archiv Allergy Immunol 2000;123:259–267.
31. Russell REK, Culpitt SV, DeMatos C, Donnelly L, Smith M, Wiggins J, et al. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metal oproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2002;26:602–609.
32. Lanchou J, Corbel M, Tanguy M, Germain N, Boichot E, Theret N. Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients. Critic Care Med 2003;31:536–542.
33. Lee YC, Song CH, Lee HB, Oh JL, Rhee YK, Park HS, et al. A murine model of toluene diisocyanate-induced asthma can be treated with matrix metalloproteinase inhibitor. J Allergy Clin Immunol 2001;108:1021–1026.
34. Lee KS, Jin SM, Kim HJ, Lee YC. Matrix metalloproteinase inhibitor regulates inflammatory cell migration by reducing ICAM-1 and VCAM-1 expression in a murine model of toluene diisocyanate-induced asthma. J Allergy Clin Immunol 2003;111:1278–1284.